Interview
![australia skyline]()
Daniel Takahashi, director at DKO Capital, believes there are opportunities right now despite the slowdown seen in the resource space.
November 15, 2019
Company News
Infratil Renewable Projects Leap to 755 MW Over Interim Period
November 15, 2019
Gaming Demand Accelerates NVIDIA’s Revenues Over Quarter
November 15, 2019
SCWorx Witnesses 74 Percent Revenue Increase
November 15, 2019
Lack of Large Project Deals Negatively Impacts D-BOX’s Bottom Line
November 15, 2019
Beasley Broadcast Group Acquires Overwatch Team
November 15, 2019
Anchiano Discontinues Phase 2 Codex Study
November 15, 2019
Interview
![]()
Byron King: The Top Precious Metals Sector Risk for Investors
“The first thing you should be cautious of about precious metals is not owning any, not having any in your... November 14, 2019
Video
![]()
VIDEO — Howard Klein: We’ll Bottom in Lithium 2.0, then Lithium 3.0 Will Start
INN talked to Howard Klein of RK Equity to understand more about the current state of the lithium sector and... November 14, 2019
Video
![]()
VIDEO — Jim Lennon: 3 Nickel Price Factors to Watch in 2020
Jim Lennon, senior consultant at Macquarie, talks about the current state of the nickel market and what’s ahead for the... November 14, 2019
UPDATE: Canopy Growth Dips on Disappointing Quarterly Results
During an earnings call with analysts and investors, Canopy Growth CEO Mark Zekulin said the lack of infrastructure in Ontario’s... November 14, 2019
Market News
TGOD Aligns Critical C$103 Million in Funding
After announcing that it missed on its financing targets, TGOD has pulled together C$103 million in funding by way of... November 14, 2019
Aleafia Health Gets License Update for Edible Products
While the cannabis producer has obtained two key license updates for its facility in Paris, Ontario, the company wasn't able... November 14, 2019
In-game Revenues Drive Allied Esports’ Growth for Q3 2019
Revenues from its 30,000 square foot HyperX esports arena in Nevada came to US$2.4 million over the quarter. November 14, 2019
Sarepta Therapeutics Strikes Partnership with StrideBio
The collaboration will involve developing therapies for at least eight CNS conditions as well as neuromuscular diseases. November 14, 2019